Related Experiment Videos
Side effects of ifosfamide
1Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Belgique. jean.klastersky@bordet.be
Abstract:
Ifosfamide is relatively well tolerated but it can be associated occasionally with life-threatening complications such as arrhythmias and heart failure, severe encephalopathy and hemorrhagic cystitis. Mesna administration can control the urothelial toxicity of ifosfamide, but it is without effect on the other complications. Other preventive measures, such as amifostine or methylene blue administration, have not yet been adequately evaluated in a sufficient number of patients. Clinicians prescribing ifosfamide, especially in high doses, should be watchful for early signs of toxicity in order to discontinue ifosfamide administration soon enough to avoid development of major toxicity.
Insights
Ifosfamide is generally well-tolerated, but serious complications like heart failure and encephalopathy can occur. Early detection and discontinuation are crucial for managing ifosfamide toxicity, as Mesna only prevents bladder issues.
Area of Science:
- Oncology
- Pharmacology
- Toxicology
Background:
- Ifosfamide is an alkylating agent used in cancer chemotherapy.
- While generally tolerated, it carries risks of severe, life-threatening toxicities.
- Existing countermeasures like Mesna are limited in their protective scope.
Purpose of the Study:
- To review the potential complications associated with ifosfamide treatment.
- To discuss current and potential strategies for mitigating ifosfamide-induced toxicities.
- To emphasize the importance of vigilant clinical monitoring for early toxicity detection.
Main Methods:
- Literature review of ifosfamide-related adverse events and management strategies.
- Analysis of the efficacy of Mesna and other potential prophylactic agents.
- Clinical guidance synthesis for safe ifosfamide prescription.
Main Results:
- Ifosfamide can cause arrhythmias, heart failure, encephalopathy, and hemorrhagic cystitis.
- Mesna effectively prevents hemorrhagic cystitis but not other severe toxicities.
- Amifostine and methylene blue lack sufficient clinical evaluation for ifosfamide toxicity prevention.
Conclusions:
- Close patient monitoring for early signs of ifosfamide toxicity is essential.
- Prompt discontinuation of ifosfamide is critical to prevent severe complications.
- Further research is needed to establish effective preventive measures beyond Mesna.
Related Concept Videos
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Overview
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drug Toxicity: Risk factors
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...